This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anil K. Lalwani, MD; Kenneth M. Grundfast, MD

Arch Otolaryngol Head Neck Surg. 1993;119(10):1074-1081.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THE 40 years that have passed since the discovery of the structure of the DNA molecule, molecular biology has rapidly evolved from basic science research to having diagnostic and therapeutic clinical applications. Research is in progress to identify the genes for deafness and craniofacial anomalies as well as the development of novel therapeutic modalities, including gene therapy for head and neck cancer. Otolaryngologists have been active participants and have made significant contributions in the clinical as well as the basic science advances in molecular characterization of diseases.

A partial list of disorders of interest to the otolaryngologist for which genes have been identified include the following: Waardenburg syndrome, Alport syndrome, Hunter syndrome, Hurler syndrome, Huntington's disease, osteogenesis imperfecta, and neurofibromatosis types 1 and 2.^1-11 Numerous other otolaryngologic disorders that have been localized to narrow chromosomal regions include the following: X-linked progressive mixed deafness with perilymphatic gusher, Usher syndrome, . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md; Washington, DC

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?